title: Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
abstract: BACKGROUND
  There are recommendations regarding the total dose of hydrocortisone to be administered in the treatment of classical congenital adrenal hyperplasia (CAH) to achieve the twin objectives of glucocorticoid replacement and control of hyperandrogenism. However, there is evidence gap regarding the breakup, timing and type of the steroid regimen.
  
  
  OBJECTIVE
  Efficacy of three different glucocorticoid regimens having the same total dose of steroid, differing in either the timing or type of evening steroid administered, in achieving biochemical control of the disease was assessed.
  
  
  METHODS
  The study was done in 13 prepubertal children with classical CAH over a 6-month period with 2 months devoted to each regimen. We used a prospective cross-over design using 10-15 mg/m(2) total dose of hydrocortisone. Two-fifths of the total dose of hydrocortisone was administered in the morning and one-fifth of the total dose was administered at noon in all the regimens. The regimens differed in the timing of the evening dose of hydrocortisone, 06.00-07.00 pm in regimen 1 and 09.00-10.00 pm in regimen 2. The third regimen had the evening dose of hydrocortisone replaced by an equivalent dose of prednisolone suspension which was administered at 10.00 pm. Serum 17-hydroxyprogesterone and testosterone levels were compared to assess the efficacy of treatment regimens.
  
  
  RESULTS
  The three different regimens were found to be similar in their ability to control 17-hydroxyprogesterone and testosterone levels. The percentage of patients with predefined criteria for biochemically controlled disease was similar in all the three regimens. However, there was a trend toward better control of 17-hydroxyprogesterone levels in patients receiving evening dose of prednisolone.
  
  
  CONCLUSIONS
  There is no significant advantage in administering the hydrocortisone dose late at night in patients with classical CAH.
authors.affiliation: Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
authors.forename: T P
authors.initials: TP
authors.lastname: Ajish
authors.affiliation: Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
authors.forename: V P
authors.initials: VP
authors.lastname: Praveen
authors.affiliation: Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
authors.forename: B
authors.initials: B
authors.lastname: Nisha
authors.affiliation: Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
authors.forename: Harish
authors.initials: H
authors.lastname: Kumar
keywords: Congenital adrenal hyperplasia; glucocorticoid; hydrocortisone; prednisolone; regimen